Inovio Pharmaceuticals Inc (INO)

[pistol1p]

I agree that nothing negative has happened on the science and clinical side of INO. Not more than a week ago I was predicting a pps of $14-$15 this week. The positive phase 2 data, and the thought of possible partnership opportunities going forward.

I was buying shares last week. Since I felt that after the phase 2 trial validated INO approach to the treatment of ID and cancer, INO would find a base from which the pps would go higher on more positive news.

The combination of outside influences (shorts and negative articles) and Dr. Kim's propensity to raise money post news, has sent INO's pps tumbling lower.

In the last year, INO's pps has dropped between 14% and 49% six times within the period of a week to 10 days. These price fluctuations, while they might be good for the seasoned trader, the shorts, and the flippers, I agree with others that it does little to instill confidence in new investors.

I also agree that the long term longs will get paid off eventually, but it is a little frustrating to see the traders, flippers and shorts continually paid off while many of us wait for our payday.

It's Dr. Kim's company, and he seems to be on a mission to change the way cancer and ID are treated. Most of us invested in INO because we feel that he will be successful. I just don't think his focus on his mission should preclude him from considering the loyal INO retail investors.